727 related articles for article (PubMed ID: 26153510)
1. Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.
Takizawa S; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Mizuma A; Yutani S; Nakayama T; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K;
J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2143-8. PubMed ID: 26153510
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
[TBL] [Abstract][Full Text] [Related]
3. Non-vitamin k antagonist oral anticoagulants do not increase cerebral microbleeds.
Saito T; Kawamura Y; Sato N; Kano K; Takahashi K; Asanome A; Sawada J; Katayama T; Hasebe N
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1373-7. PubMed ID: 25847305
[TBL] [Abstract][Full Text] [Related]
4. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
Umemura T; Mashita S; Kawamura T
PLoS One; 2020; 15(9):e0238456. PubMed ID: 32941455
[TBL] [Abstract][Full Text] [Related]
6. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229
[TBL] [Abstract][Full Text] [Related]
8. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED
Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
[TBL] [Abstract][Full Text] [Related]
10. New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up.
Orken DN; Uysal E; Timer E; Kuloglu-Pazarcı N; Mumcu S; Forta H
Clin Neurol Neurosurg; 2013 Sep; 115(9):1682-5. PubMed ID: 23623660
[TBL] [Abstract][Full Text] [Related]
11. New cerebral microbleeds in AF patients on non-vitamin K oral anticoagulants or warfarin: One-year follow-up.
Zhuang L; Zhai L; Qiao S; Hu X; Lai Q; Fu F; Cheng L; Liu L; Liu X; Wang J
Medicine (Baltimore); 2022 Feb; 101(7):e25836. PubMed ID: 35363159
[TBL] [Abstract][Full Text] [Related]
12. Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-Warfarin study.
Soo Y; Abrigo JM; Leung KT; Tsang SF; Ip HL; Ma SH; Ma K; Fong WC; Li SH; Li R; Ng PW; Wong KK; Liu W; Lam BYK; Wong KSL; Mok V; Chu WCW; Leung TW;
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):428-435. PubMed ID: 30554138
[TBL] [Abstract][Full Text] [Related]
13. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
14. Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.
Lee SR; Choi EK; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
Stroke; 2019 Jun; 50(6):1480-1489. PubMed ID: 31084339
[TBL] [Abstract][Full Text] [Related]
15. A review of oral anticoagulants in patients with atrial fibrillation.
Greenspon AJ
Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach.
Verdecchia P; Angeli F; Bartolini C; De Filippo V; Aita A; Di Giacomo L; Poltronieri C; Lip GY; Reboldi G
Expert Opin Drug Saf; 2015 Jan; 14(1):7-20. PubMed ID: 25311731
[TBL] [Abstract][Full Text] [Related]
18. Early administration of non-vitamin K antagonist oral anticoagulants for acute ischemic stroke patients with atrial fibrillation in comparison with warfarin mostly combined with heparin.
Nomura E; Ohshita T; Imamura E; Wakabayashi S; Kajikawa H; Hosomi N; Matsumoto M
Circ J; 2015; 79(4):862-6. PubMed ID: 25736910
[TBL] [Abstract][Full Text] [Related]
19. Microbleeds and Outcome in Patients With Acute Ischemic Stroke and Atrial Fibrillation Taking Anticoagulants.
Choi KH; Kim JH; Lee C; Kim JM; Kang KW; Kim JT; Choi SM; Park MS; Cho KH
Stroke; 2020 Dec; 51(12):3514-3522. PubMed ID: 33028171
[TBL] [Abstract][Full Text] [Related]
20. Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Hu MM; Wang J; Chien KL; Su CL; Lin SY; Wu FL; Lin ZF
J Formos Med Assoc; 2017 Apr; 116(4):276-286. PubMed ID: 27424804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
